Junxin Wu

15PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 23, 2026
EFHD2 drives lactate-mediated DNA damage repair and immunosuppression via HMGB1 and HIF-1α to confer radioresistance in colorectal cancer.

|Dec 08, 2025
HERV6196 as an enhancer with oncogenic potential in rectal cancer.

Yi-Xiu Gan, Xin Jiang, Zhi-Yu Wang

|Sep 30, 2025
Immune system development-related signature predicts prognosis and sorafenib-treatment resistance of hepatocellular carcinoma by intergrating machine learning and single-cell analyses.

Shiji Wu, Xingte Chen, Huipeng Fang

|Feb 18, 2025
G2M-checkpoint related immune barrier structure and signature for prognosis and immunotherapy response in hepatocellular carcinoma: insights from spatial transcriptome and machine learning.

Xingte Chen, Shiji Wu, Hongxin He

|Nov 28, 2024
Novel signature of ferroptosis-related long non-coding RNA to predict lower-grade glioma overall survival.

Shiji Wu, Wenxi Wu, Yaqi Zhong

|Oct 28, 2024
Developing Individualized Follow-Up Strategies Based on High-Risk Recurrence Factors and Dynamic Risk Assessment for Locally Advanced Rectal Cancer.

Jianjian Qiu, Yilin Yu, Zhiping Wang

Pageof 3

Frequent Collaborators

3 joint publications

Jinluan Li

1 joint publications

Yun-Xia Huang

1 joint publications

Yi-Xiu Gan

1 joint publications

Jian-Min Wang